Light Mode
$0.2140 ↑ +0.0000 (+0.00%) Trading Up from the previous close of $0.2140, $0.0130 below the day’s high of $0.2270
-2.18 (-91.05%) / 6M
Momentum, market sentiment, and recent alerts
ABOS reads poor: price sits below both the 20- and 200-day averages, the 12-month move is -87.6%.
Earnings, valuation, and balance sheet
Company profile and competitor comparison
Acumen Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which engages and develops medicines and diagnostics for Alzheimer's disease. The company was founded by William L. Klein, Grant A. Krafft, and Caleb Finch in 1996 and is headquartered in Newton, MA.
Real-time scanning and AI-generated signals across the entire market.
Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.